VMC vs ZYME · P/E 35, rev $7.42B vs rev $76.3M
Vulcan Materials Company (VMC) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
VMC currently screens at market cap $38.25B and trailing P/E 34.9. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the VMC and ZYME stock pages for the full models.
Not investment advice.